RIPK3 and melanoma: This study is the first report providing evidence that inhibition of the melanogenesis process in the pigmented melanoma cells induces the RIPK1/RIPK3/MLKL-dependent necroptosis, a form of caspase-independent cell death, which represents one of the most promising anticancer therapeutic modalities to eliminate apoptosis-resistant tumor cells.